Fig. 4From: Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial dataResults comparing naïve and IV model estimates from IG and Cox models. Regression estimates and 95% CI for dose effect on time to remission under the Cox (PH), log HR, and inverse Gaussian (IG), velocity coefficient, models. Estimates shown without (naïve) and with (IV) the stage 1 residuals introduced as control variables. Results from fully adjusted modelsBack to article page